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ABSTRACT
Egg activation at fertilization in mammals is initiated by prolonged
Ca2+ oscillations that trigger the completion of meiosis and
formation of pronuclei. A fall in mitogen-activated protein kinase
(MAPK) activity is essential for pronuclear formation, but the precise
timing and mechanism of decline are unknown. Here, we have
measured the dynamics of MAPK pathway inactivation during
fertilization of mouse eggs using novel chemiluminescent MAPK
activity reporters. This reveals that the MAPK activity decrease
begins during the Ca2+ oscillations, but MAPK does not completely
inactivate until after pronuclear formation. TheMAPKs present in eggs
are Mos, MAP2K1 and MAP2K2 (MEK1 and MEK2, respectively) and
MAPK3 and MAPK1 (ERK1 and ERK2, respectively). Notably, the
MAPK activity decline at fertilization is not explained by upstream
destruction of Mos, because a decrease in the signal from a Mos–
luciferase reporter is not associated with egg activation. Furthermore,
Mos overexpression does not affect the timing ofMAPK inactivation or
pronuclear formation. However, the late decrease in MAPK could be
rapidly reversed by the protein phosphatase inhibitor, okadaic acid.
These data suggest that the completion of meiosis in mouse zygotes
is driven by an increased phosphatase activity and not by a decline in
Mos levels or MEK activity.
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INTRODUCTION
Before fertilization, mammalian oocytes are arrested at the
second metaphase of meiosis. Upon fertilization, fusion with the
sperm causes the egg to complete meiosis and the zygote to enter
the first interphase of embryo development. The unfertilized egg
is arrested in metaphase II as a result of the continuous activity of
two main types of protein kinase (Carroll, 2001; Ducibella and
Fissore, 2008). One of these is maturation-promoting factor
(MPF), which consists of cyclin-dependent kinase 1 (CDK1) and
cyclin B1 (Ducibella and Fissore, 2008; Madgwick and Jones,
2007). The other is a mitogen-activated protein kinase (MAPK)
pathway, which comprises MAPK3 and MAPK1 (hereafter
referred to as ERK1 and ERK2, respectively), which are
stimulated by the sequential action of two upstream protein
kinases, Mos and MAP2K1 and MAP2K2 (hereafter referred to as
MEK1/2) (Verlhac et al., 1994; Verlhac et al., 1996; Dupre´ et al.,
2011). Both MPF and the MAPK pathway become active during
the final stages of oocyte maturation as the oocytes transition
from arrest at the germinal vesicle stage through meiosis to arrest
at meiotic metaphase II (Verlhac et al., 1994; Verlhac et al., 1996;
Dupre´ et al., 2011). The increase in MAPK pathway activity is
stimulated during maturation by increased synthesis of the
upstream activator Mos. Exit from meiosis and entry into
interphase at fertilization only occurs after both MPF and
MAPK activities have undergone a large decrease (Verlhac
et al., 1994; Moos et al., 1995; Moos et al., 1996). In frog,
ascidian and mammalian eggs, the decline in MPF activity is
known to be primarily due to the proteolysis of cyclin B, which is
triggered by the activation of the protease activity of the
anaphase-promoting complex (APC). The APC itself is
stimulated by the destruction of Emi2 (Madgwick and Jones,
2007). Emi2 acts as an inhibitor of the APC and as a stabilizer of
metaphase II, and is itself stabilized by Mos-stimulated MAPK
activity (Suzuki et al., 2010; Dupre´ et al., 2011). The loss of Emi2
and cyclin B, and the subsequent decline in MPF activity can
explain the earliest events of meiotic resumption, such as
metaphase anaphase transition and the second polar body
emission (Shoji et al., 2006; Suzuki et al., 2010). However,
MAPK activity is high for longer than MPF activity in order to
maintain spindle integrity in the events leading up to second polar
body emission (Verlhac et al., 1994; Petrunewich et al., 2009).
MAPK pathway inactivation appears to be delayed until around
the time of pronuclear formation, which signals the end of egg
activation and marks the entry into interphase of the first cell cycle
(Verlhac et al., 1994; Marangos et al., 2003). Experiments using
constitutively active MEK or phosphatase inhibitors, such as
okadaic acid, have shown that there is an absolute requirement for a
fall in MAPK activity before pronuclei are formed in mouse zygotes
(Moos et al., 1995; Moos et al., 1996). However, other studies on
artificially activated eggs suggest that MAPK dephosphorylation
might not occur until after pronuclear formation, and so the role of a
decline MAPK activity in this event has been questioned (Soeda
et al., 2013). However, unlike MPF, the exact timing of MAPK
inactivation has not been measured and there are no evident causal
links between the signaling pathways triggered by the sperm and the
delayed decline in MAPK activity.
The initial signal that the fertilizing sperm triggers in order to
release the egg from metaphase II arrest in vertebrates is a large
Ca2+ increase in the egg cytosol (Stricker, 1999; Ducibella and
Fissore, 2008). In frogs, the sperm triggers a single Ca2+ increase,
whereas in mammals sperm–egg fusion leads to a prolonged series
of Ca2+ oscillations (Stricker, 1999). In mammalian eggs, there is
substantial evidence suggesting that the sperm causes these Ca2+
oscillations by the introduction of a sperm-specific phospholipase
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C, PLCf, after gamete membrane fusion (Saunders et al., 2002).
PLCf then hydrolyzes its substrate phosphatidylinositol (4,5)-
bisphosphate (PIP2) to drive repetitive cycles of inositol
trisphosphate (IP3) production and Ca
2+ release that last for
several hours (Swann and Lai, 2013). In mouse eggs, the Ca2+
oscillations eventually stop at the time of pronuclear formation
(Marangos et al., 2003; Ito et al., 2008) owing to the sequestration
of PLCf within the nascent pronuclei (Larman et al., 2004). In both
frogs and mammals, the Ca2+ signal stimulates Ca2+/calmodulin-
dependent protein kinase II (CaMKII), which leads to
phosphorylation of Emi2 and eventually results in Emi2
proteolysis (Madgwick and Jones, 2007). Hence, the Ca2+ signals
have been linked to the loss of MPF activity (Madgwick and Jones,
2007; Suzuki et al., 2010). In contrast, the decline in MAPK
activity occurs several hours later and has not been linked to Ca2+
signals (Verlhac et al., 1994; Marangos et al., 2003). Because the
activation of the MAPK pathway comprises the protein kinase
cascade of Mos, MEK and ERK1/2, it is possible that the late fall in
MAPK could be linked to a destruction of Mos, and then a loss of
MEK activity (Dupre´ et al., 2011). This model is supported in
ascidian oocytes, where the overexpression of Mos prevents the
decline in MAPK and blocks pronuclear formation (Dumollard
et al., 2011). Also in support of this idea, Mos protein in mouse
eggs has been shown to decline at some time between second polar
body emission and pronuclear formation during parthenogenetic
activation (Weber et al., 1991). However, whether this decline in
Mos levels correlates with, or is required for, a decline in MAPK
activity and pronuclear formation is unclear. Furthermore, Mos
appears to be unstable in mouse eggs because Mos protein levels
also decline over several hours in unfertilized eggs (Shoji et al.,
2006). Hence, the presumed link between the loss of Mos and the
fall in MAPK activity in mammalian eggs has remained
unresolved.
The timing of cyclin B destruction at fertilization in mouse
eggs has been monitored in real time by imaging the loss of either
GFP- or luciferase-tagged fusion proteins (Nixon et al., 2002;
Marangos and Carroll, 2004; Ajduk et al., 2008). The decline in
cyclin B levels can be an effective surrogate for the fall in MPF
activity, and its decline starts during the initial Ca2+ rise. The fall
in MPF is then completed within the next two or three Ca2+
spikes, which are within 20 min of the initial Ca2+ increase
(Nixon et al., 2002; Marangos and Carroll, 2004; Ajduk et al.,
2008). Despite the significance of MAPK in cell cycle transitions
in eggs, there are no comparable dynamic imaging studies on cell
cycle changes in Mos levels or MAPK activity. This might be
primarily because Mos protein is present at very low (,nM)
levels in eggs, which is below the typical detection limit of
fluorescent proteins (Ferrell, 1996; Niswender et al., 1995).
Furthermore, the changes in MAPK activity are caused by a
dephosphorylation of ERK1 and not its proteolysis, and so the
relevant change in MAPK can only be detected using groups of
eggs combined with either in vitro kinase assays or western blots
using antibodies against phosphorylated proteins (Verlhac et al.,
1994; Moos et al., 1995). In this study, we have applied a split-
luciferase-based probe to monitor the activity of the MAPK
pathway. This activity indicator reports the conformational
change in ERK1 that occurs upon phosphorylation by MEK
(Khokhlatchev et al., 1998; Cobb and Goldsmith, 2000). This
chemiluminescent indicator has been used to demonstrate the
precise timing of decrease in ERK1 phosphorylation in relation to
the sequence of Ca2+ oscillations during fertilization of mouse
eggs. The data suggest that MAPK activity starts to decrease
several spikes prior to the cessation of the series of Ca2+
transients but that the complete inactivation of MAPK does not
occur until after pronuclei have formed. We have also examined
changes in recombinant Mos in fertilizing mouse eggs using a
Mos–luciferase fusion protein, which can be detected at low
expression levels. We show that there is no measurable increase
in Mos–luciferase destruction at fertilization, and that
overexpression of Mos does not affect the timing of MAPK
activity decrease or the formation or pronuclei. By contrast, our
data show that the fall in MAPK pathway activity during the final
stages of egg activation is driven by an increase in okadaic-acid-
sensitive phosphatase activity.
RESULTS
Monitoring MAPK activity with the ERK1 split-luciferase
reporter MAPKAR
In order to measure changes in MAPK activity within intact
mouse eggs, we designed a genetically-encoded bioluminescent
reporter that is capable of monitoring the activity of the terminal
protein kinase in the MAPK pathway, namely ERK. This new
luciferase reporter is a single molecule that consists of two
tandem ERK1 sequences inserted between the N- and C-terminal
portions of click beetle luciferase and is referred to as a MAPK
activity reporter or MAPKAR. Fig. 1 is a schematic diagram of
the design of the reporter. Fig. 2A shows the luminescence from
unfertilized mouse eggs injected with cRNA encoding the
MAPKAR. The luminescent signal was maintained at a low
level in unfertilized eggs, but it increased substantially after
addition of the MEK inhibitor U0126 (Fig. 2B). U0126 has been
shown to be a specific inhibitor of MEK in mouse eggs and its
application leads to the dephosphorylation of ERK1/2 in mouse
eggs (Phillips et al., 2002). Consequently, the data suggest that
MAPKAR undergoes a conformational change that causes
an increase in luminescence when ERK1 dephosphorylation and
inactivation occurs (Fig. 1). Thus, a decreased interaction
between the two ERK1 moieties within MAPKAR enables
structural and functional reassociation of the N- and C-terminal
Fig. 1. Schematic illustration of the MAPKAR. Two tandem ERK1
monomers were inserted between the N-terminal and C-terminal fragments
of click beetle luciferase, and coupled by a flexible glycine-serine (G/S) linker.
MAPK activation (phosphorylation and ERK1 interaction) keeps the split-
luciferase halves apart and no emission of luminescence occurs. MAPK
inactivation triggers a conformational change that brings the split luciferase
halves together and a luminescent signal is emitted.
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domains of click beetle luciferase to reconstitute bioluminescence
activity, as has been proposed for the firefly split-luciferase
reporter of Akt kinase activity (Zhang et al., 2007). In order
to make the interpretation of traces more intuitive, note that
the luminescent recordings are inverted so that the inactivation of
ERK1 corresponds to a downward deflection in the trace.
From Fig. 2B it is evident that the luminescence signal change
upon U0126 addition is about ten-fold, given that starting
luminescence values were 0.1–0.5 counts per second (cps)
and after U0126 treatment the signal increases were typically
4–5 cps.
Previous studies have shown that ERK1/2 monomers undergo
dimerization upon phosphorylation (Cobb and Goldsmith, 2000).
We also generated a related chemiluminescent reporter based upon
an altered version of ERK1 that cannot dimerize owing to the
deletion of four residues (Lidke et al., 2010). This interaction-
deficient ERK1 reporter, which was designed and constructed as for
MAPKAR, is referred to as MAPKARD4. When MAPKARD4 was
injected into eggs, it showed a higher basal expression level
(luminescence .3 cps) compared to that of MAPKAR (Fig. 2C).
Upon addition of U0126, the MAPKARD4-injected eggs showed a
similar order of magnitude change in luminescence as found
for MAPKAR (Fig. 2B). The higher basal luminescence for
MAPKARD4 indicates interaction between the N- and C-terminal
luciferase fragments likely occurs owing to the defective interaction
between the ERK1 moieties. However, because MAPKARD4
shows a large change in luminescence after U0126 treatment, it
suggests that, after dephosphorylation, there is further considerable
movement of the interaction-deficient ERK1 subunits.
In order to establish that the above luminescence signal
changes are dependent upon phosphorylation, a further ‘MAPK
reporter’ lacking the two phosphorylation sites (T202, Y204) in
each of the ERK1 monomer sequences was produced (Cobb and
Goldsmith, 2000). This related construct to those described
above, is referred to as the ERK1 phosphorylation double mutant
(MAPK-DM). Unlike the other MAPKAR, MAPK-DM cannot be
phosphorylated in the unfertilized egg. When the cRNA for
MAPK-DM was injected into mouse eggs there was a clear
luminescence signal in unfertilized eggs in the absence of any
stimuli (Fig. 2D). The subsequent addition of U0126 did not have
any effect on the luminescence signal in any of the eggs recorded.
This suggests that the U0126-mediated luminescence changes
seen with the MAPKAR and MAPKARD4 proteins require specific
phosphorylation of the T202 and Y204 residues (Fig. 2D).
The luminescence changes in MAPKAR-injected eggs treated with
U0126 were next correlated with the dephosphorylation patterns of
both the endogenous ERK1 and recombinant MAPKAR. The
immunoblots in Fig. 2E show that phosphorylation of ERK1 in
untreated eggs and its dephosphorylation following U0126 addition
both exhibited a pattern that is entirely consistent with the
luminescence recordings. Immunoblot analysis further indicated
that the expressed MAPKARD4 was also dephosphorylated at the
same time as the endogenous ERK1 in mouse eggs exposed to U0126
(Fig. 2F). We note from these immunoblots that the MAPKAR probes
were expressed at much lower concentrations than the endogenous
ERK1/2. The longer exposures used to reveal the MAPKAR probes
meant there was poor resolution of separate ERK1 and ERK2 bands
that can otherwise be seen in supplementary material Fig. S1. Taken
Fig. 2. The response of MAPKAR and its
variants to U0126. The luminescence
recordings (in counts per 10 seconds) are
shown from sample eggs previously injected
with cRNA encoding for each probe and
incubated in 100 mM luciferin. (A) The egg was
left for several hours without addition of drugs
(one trace is shown that is representative of 10
eggs). (B) 50 mM of the MEK inhibitor U0126
was added to an egg expressing MAPKAR at the
time indicated by the arrow, which leads to an
increase in luminescence (one trace is shown
that is representative of 26 eggs). (C) 50 mM
U0126 was added to an egg expressing
MAPKARD4 (one trace is shown that is
representative of 53 eggs), and (D) 50 mM of
U0126 was added to an egg expressing MAPK-
DM (one trace is shown that is representative of
27 eggs). (E,F) Western blots using antibodies
against diphosphorylated ERK1/2 and ERK1/2.
Eggs (groups of 50–60) were injected with either
MAPKAR (E) or MAPKARD4 (F) cRNA and
incubated for 3–4 h. In E, the first lane is from
eggs expressing MAPKAR, and the second lane
from eggs that were treated with 50 mM U0126
for the last hour before lysis in sample buffer.
The upper blot is with antibody against
diphosphorylated (DiP) ERK1/2, and the lower
blot with anti-ERK1/2 antibodies. In F the
conditions are the same as in E with control
eggs and those treated with 50 mM U0126,
except that the eggs were expressing the
MAPKARD4 probe for both lanes.
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together, these results show that the luminescence signal changes
derived from these various MAPKAR expression constructs appear to
faithfully report ERK1 phosphorylation and hence activation of the
MAPK pathway in mouse eggs. In view of their place in the MAPK
pathway (downstream of MEK), the MAPKAR luminescent probes
can be regarded as surrogate reporters for the state of ERK1
phosphorylation and, hence, the degree of activation of MEK, the
penultimate kinase in the MAPK pathway.
MAPK dynamics during fertilization
Using MAPKAR and MAPKARD4, we then examined the timing
of the decrease in MAPK activity during fertilization. We carried
out experiments where the luminescence of our MAPK probes
was measured alongside the fluorescence of a Ca2+-sensitive dye.
Fig. 3A shows a typical recording from mouse eggs during
fertilization, simultaneously measuring both Ca2+ oscillations and
the luminescence signal changes from MAPKAR. Images of the
luminescent eggs before and after fertilization are shown in the
insets in Fig. 3A–C. In all experiments, the luminescence was
low before fertilization and during the early phase of the Ca2+
transients. After a couple of hours, there was a change in
luminescence that started before, but was not completed until
well after, the cessation of Ca2+ oscillations. In fertilized eggs
where we monitored the full series of Ca2+ oscillations and
change in MAPKAR signal, the time period from the first Ca
2+
increase to the cessation of Ca2+ oscillations was 4 h 5 min
(610 min, s.e.m.), whereas the time that had elapsed between the
first Ca2+ transient and the half maximal change in MAPKAR
luminescence was 6 h 38 min (617 min, s.e.m.; 41 fertilized
eggs from four separate experiments). The change in
luminescence commenced at between 2 and 3 h after the
initiation of Ca2+ oscillations. In every experiment where there
was a detectable luminescence signal at the beginning of Ca2+
oscillations, the inflection point indicating the start of the change
in MAPKAR luminescence always occurred before the last of the
series of Ca2+ oscillations. In many, but not all cases, there
appeared to be two phases of luminescence change with one
phase before and another after the cessation of Ca2+ oscillations.
Fertilization experiments were also conducted using
MAPKARD4 (Fig. 3B). With this reporter there was a higher
basal luminescence during the initial phase of the Ca2+ transients.
As for MAPKAR, there was an even more distinct change in
MAPKARD4 luminescence observed towards the end of the series
of Ca2+ oscillations that continued for several hours after the
Fig. 3. MAPK changes during fertilization. (A) An egg expressing
MAPKAR and injected with OGBD was fertilized and its
luminescence recorded alongside Ca2+ oscillations (the
fluorescence of OGBD dye measuring Ca2+ are in arbitrary units).
The change in luminescence towards the end of the series of Ca2+
oscillations is typical of 41 eggs. (B) A similar experiment to A,
except that the MAPKARD4 probe was used, and the recording
shown is typical of 23 eggs. (C) Another recording from a
MAPKARD4-injected egg where the luminescence trace was not
filtered, in order to illustrate the nature of the start of the change in
MAPKARD4 luminescence during fertilization. The images on the
right-hand sides of each set of traces show the luminescence of egg
for 10 min before and after fertilization (at the times in the traces
indicated by * and **, ‘BGN’ shows the background count). In A,
sperm were added to the recording dish at the point indicated by the
arrow, in B and C sperm were added before the start of the trace.
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cessation of Ca2+ oscillations (Fig. 3B,C). The start of the change
in signal for MAPKARD4 was more evident because it showed a
higher level of luminescence before a marked inflexion with the
change in luminescence often appearing as a distinct switch (e.g.
Fig. 3C). Eggs injected with MAPKARD4 that did not fertilize did
not show such an inflexion in the trace, nor did they show the
marked increase in luminescence of fertilized eggs (see
supplementary material Fig. S2). Owing to the higher initial
luminescence values, we were able to estimate that the decline in
MAPKARD4 signal started 2 h 25 min (612 min, n523, s.e.m.)
after the first Ca2+ increase at fertilization. This time point
corresponds to the occurrence of the 18th Ca2+ transient out of
25 Ca2+ transients (mean values) suggesting that the change in
MAPK begins about three quarters of the way through the
total number of Ca2+ transients. The fertilization-induced
luminescence signal with MAPKARD4 also showed signs of a
two-phase change, with one phase before and another after the
cessation of Ca2+ oscillations. It is known that the cessation of
Ca2+ oscillations in mouse zygotes correlates with the time of
pronuclear formation (Marangos et al., 2003). It was noteworthy
that when we fertilized eggs injected with the MAPK-DM, which
is a version of our probes that cannot be phosphorylated, there
was no distinct change, or distinct inflexion in the trace, as seen
with the MAPKAR and MAPKARD4 probes (supplementary
material Fig. S3.) These data show that the changes in
luminescence we see with the MAPKAR and MAPKARD4
probes reflect phosphorylation of ERK1. Consequently, our
data with two different ERK1-based reporters suggest that the
onset of MAPK inactivation starts abruptly towards the end of the
series Ca2+ oscillations at fertilization, a point well before
pronuclear formation. However, the MAPK inactivation then
continues progressively for a considerable time after pronuclear
formation.
The role of Mos in MAPK inactivation and
pronuclear formation
The delayed decrease in MAPK activity at fertilization could be
due to delayed destruction of Mos protein. We therefore
investigated the stability of Mos during fertilization by making
a Mos–luciferase (Mos–luc) fusion protein, in a similar approach
to previous studies of cyclin B stability (Nixon et al., 2002; Ajduk
et al., 2006). Fig. 4A shows the luminescence recorded from a
fertilizing egg expressing Mos–luc, as well as the Ca2+
oscillations measured with a fluorescent dye. Because Mos is
considered to be present at a very low concentration in eggs, we
injected small amounts of Mos–luc cRNA to produce a low
luminescence signal consistent with the level of reporter
expression (see Discussion). Fig. 4A shows that there was a
steady decline in Mos–luc luminescence before the egg was
fertilized. During the series of Ca2+ oscillations produced at
fertilization the luminescence decline continued at the same rate.
However, towards the end of the Ca2+ oscillations there was a
distinct increase in Mos–luc luminescence seen in all fertilized
eggs (Fig. 4A). The increase in Mos–luc luminescence late in
fertilization likely arises from the synthesis of Mos–luc protein
from the injected cRNA exceeding the rate of protein destruction.
We could prevent this increase by injecting eggs sequentially
with Mos–luc cRNA, and then 3 h later, with Mos–luc antisense
RNA to inhibit further Mos–luc expression. In this case, the
distinct increase was absent and a steady decline in Mos–luc
luminescence was maintained during fertilization (Fig. 4B).
These data, using two different protocols, suggest that Mos
does not undergo increased destruction during fertilization-
induced Ca2+ oscillations in mouse eggs.
We next wanted to investigate whether overexpression of Mos
would perturb the temporal profile of the MAPK decrease or the
formation of pronuclei. Mos overexpression has previously been
shown to block MAPK inactivation in fertilizing ascidian eggs,
and this response is seen with Mos from a variety of species
(Dumollard et al., 2011). We were not able to monitor MAPKAR
alongside Mos–luc because they both generate the same
luminescent signal, so we used the same Mos–Cherry construct
that was used effectively in ascidian oocytes (Dumollard et al.,
2011). Fig. 5A,B depicts the changes in the MAPKAR or
MAPKARD4 signal in mouse egg co-injected with ascidian
Mos–Cherry. In both instances, the change in luminescence
occurred in a similar manner to that in control eggs and all such
mouse eggs expressing Mos–Cherry also formed pronuclei. For
eggs expressing MAPKARD4 and Mos–Cherry, the time from the
initial Ca2+ transient to the point at which MAPK started to
decline was 1 h 54 min (67 min; n520, s.e.m.). This is not
significantly different to the 2 h 2 min (65 min, n513, s.e.m.)
observed for the corresponding time for control eggs not
expressing Mos–Cherry, and which were simultaneously
fertilized in the same experiment. The average level of Mos–
Cherry fluorescence in all these experiments was ,5 times
Fig. 4. Changes in Mos–luc luminescence during fertilization. Eggs were injected with Mos–luc cRNA and OGBD and allowed to express Mos–luc
before fertilization. (A) An example of an egg (typical of 19 eggs) that was fertilized, as indicated by the presence of Ca2+ oscillations. The Mos–luc
luminescence is shown in the lower trace. (B) An example of a representative egg injected sequentially with Mos–luc RNA and antisense Mos–luc (3 h later),
and OGBD before the start of the recording. Sperm were added (at the arrow in B and before the start of the trace in A) and eggs started fertilization at the time
marked by the Ca2+ oscillations. The Mos–luc luminescence is shown on the lower trace (one of 29 similar recordings).
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greater than the egg autofluorescence. These data suggest that
Mos expression in mouse eggs does not affect the onset or the
subsequent time course of the decline in the MAPK pathway
activity at fertilization.
We also examined whether the mouse Mos–luc itself could
affect the time course of pronuclear formation because this
depends upon a decline in MAPK levels (Moos et al., 1996).
Because the first Ca2+ transients initiate the events of metaphase–
anaphase transition, and the termination of Ca2+ oscillations is
precisely correlated with pronuclei formation in mouse eggs, we
again used the start and cessation of Ca2+ oscillations as a proxy
for measuring the period required for eggs to form pronuclei and
enter interphase. Fig. 5C shows an example of Ca2+ oscillations
recorded from a fertilizing mouse egg injected with a high
concentration of Mos–luc cRNA to induce luminescence
expression levels ,1000 times higher than in the above
experiments (Fig. 5A,B). The Ca2+ oscillations in the presence
of high Mos–luc luminescence displayed a similar pattern to
control eggs. There is a slight decline in Mos–luc before
fertilization, but no major loss of this signal during fertilization.
Fig. 5C shows, in fact, that after Ca2+ oscillations start there is a
slight increase in luminescence, probably due to Ca2+-induced
stimulation of mitochondrial ATP production (Campbell and
Swann, 2006). These Mos–luc-injected eggs all displayed Ca2+
oscillations and pronuclei formation in a manner similar to
control eggs simultaneously fertilized in the same dish. The
duration and number of Ca2+ oscillations was 3 h 53 min
(676 min, s.d.) with 46.5 (617.7, s.d.) Ca2+ spikes for eggs
with high levels of Mos–luc injected (all 30 eggs expressing
.100 cps of Mos–luc), compared to 3 h 18 min (643 min, s.d.)
and 46.9 (623.5, s.d.) Ca2+ spikes for 18 parallel control eggs.
Consequently, these results indicate that overexpression of Mos–
luc does not alter the timing of pronuclei formation. Combined
with the above measurements of Mos–luc decline, our data
suggest that increased Mos destruction does not occur in response
to sperm-induced Ca2+ signals. In addition, the continued
presence of Mos protein in eggs does not affect the timing of
MAPK activity decrease, the occurrence and termination of Ca2+
oscillations, or the formation of pronuclei.
The decline in MAPK activity, Ca2+ signals and
pronuclear formation
Because the MAPK decline starts during the Ca2+ oscillations, we
next determined whether the dynamics of MAPK decline was
influenced by the presence or absence of Ca2+ signals. When Ca2+
oscillations are initiated in fertilized eggs, they can be stopped
by addition of sufficient BAPTA to chelate extracellular Ca2+
(Fig. 6A), but notably, the change in MAPKAR signal still
occurred as in control eggs that displayed normal Ca2+
oscillations. However, the time to reach the half-maximal
change in MAPKAR luminescence was 8 h 26 min (652 min,
s.e.m.) for BAPTA-treated eggs (n533) which is slightly longer
Fig. 5. Mos overexpression and fertilization. (A,B) Traces
from an egg injected with MAPKAR and Mos-Cherry cRNA
,4 h before the start of the recording. The sperm were
added before the start of the traces shown. The fluorescence
of Mos–Cherry was measured just before recording, and
then the fluorescence of OGBD and the luminescence of
MAPKAR (A) and MAPKARD4 (B) were recorded during
fertilization as in Fig. 3. In experiments of which A is an
example, the mean Mos–Cherry signal was 7.3 times the
background fluorescence (n512). In experiments of which B
is an example, the mean Mos–Cherry signal of the egg was
6.6 times the background fluorescence (n516). In each
case, the pattern of luminescence change was similar to
control eggs that had not been injected with Mos–mCherry
cRNA. The images show the fluorescence of Mos–Cherry in
the same eggs as shown in the traces for the start and end of
the experiment. (C) A recording from one of 30 eggs that
were injected with Mos–luc cRNA and Ca2+ dye ,3 h before
the start of the recording. Conditions were otherwise the
same as Fig. 3.
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than the mean time for control eggs reported above (6 h 38 min;
617 min, s.e.m.). This data suggests that whereas premature
termination of Ca2+ oscillations still allows MAPK inactivation,
the kinetics of inactivation are slightly delayed by the absence of
Ca2+ signals.
The converse situation to stopping the fertilization-induced
Ca2+ oscillations early can be achieved by inhibiting pronuclear
formation. In wheat germ agglutinin (WGA)-injected mouse
eggs, pronuclear formation is prevented and Ca2+ oscillations
persist for a prolonged period owing to the absence of nuclear
localization of PLCf (Marangos et al., 2003; Larman et al., 2004).
Fig. 6B shows a recording of the MAPKAR signal from a
fertilizing egg injected with WGA. As with BAPTA, the
luminescence change still occurred in the presence of WGA
(Fig. 6B). The time taken for a half-maximal change in the
MAPKAR signal was 4 h 5 min (661 min, s.e.m.) for WGA-
injected eggs (n529), which is not significantly shorter than
control fertilizing eggs. This result suggests that the ongoing
presence of Ca2+ oscillations has rather little influence upon the
start of MAPK inactivation.
In mouse eggs, the inhibition of MPF activity with roscovitine
leads to a decrease in MAPK activity in the absence of a Ca2+
increase (Phillips et al., 2002; Rogers et al., 2006). Thus, another
way of studying the influence of Ca2+ signals upon the time
course of MAPK inactivation during fertilization is to determine
the effects of roscovitine. Fig. 6C,D shows that roscovitine
addition to MAPKAR- or MAPKARD4-injected mouse eggs
caused a change in luminescence that resembles that seen in
fertilizing eggs. Roscovitine caused egg activation as indicated by
the formation of pronuclei, but it did not cause a significant Ca2+
increase under these conditions (supplementary material Fig. S4).
The delay from the addition of roscovitine to the start, and to the
half maximal change in signal, in three eggs was ,6 h for the
MAPKAR signal but was hard to define due to the lack of initial
basal luminescence with MAPKAR. The delay to the start of the
MAPKARD4 signal was 3 h 35 min (681 min; n512, s.e.m.)
after addition of roscovitine. The response to roscovitine was
more variable than at fertilization, but within the same range of
times. These data, therefore, suggest that the change in MAPKAR
and MAPKARD4 signals after roscovitine addition was similar to
that seen after fertilization, and is clearly much more delayed
compared with the addition of U0126 (Fig. 6C,D compared to
Fig. 2B,C). These data suggest that although Ca2+ oscillations
might have some small effect upon the timing of MAPK
inactivation, a decline in MPF activity alone is sufficient to
trigger the same dynamics of MAPK inactivation as seen at
fertilization.
The role of phosphatases in the decline in MAPK
The protein phosphatase inhibitor okadaic acid can prevent the
decrease in MAPK activity at fertilization and, hence, prevent the
formation of pronuclei (Moos et al., 1995). We wanted to
investigate the role of an okadaic-acid-sensitive phosphatase in
the dynamics of MAPK inactivation. However, okadaic-acid-
sensitive phosphatases, such as PP2A, play a role in meiotic arrest
and early application of okadaic acid can itself cause a decline in
MPF levels (Chang et al., 2011). To avoid interference in these
early events of egg activation, we added okadaic acid after Ca2+
oscillations had proceeded for .1 h (after MPF will have
declined). In Fig. 7A, after the MAPKARD4 signal had started to
change, we found that there was change in luminescence, which
reverted back to unfertilized levels. There was also a persistence
of Ca2+ oscillations after adding okadaic acid, which is probably
caused by the fact that okadaic acid prevents pronuclear
formation, which blocks PLCf nuclear localization (Larman et al.,
2004). Similar results were seen when the MAPKAR probe was
applied to fertilizing eggs (see supplementary material Fig. S5).
These data suggest that okadaic acid can prevent a decrease in
ERK1 activity after the initiation of the decline in ERK1 signaling.
Because ERK1 phosphorylation is restored after okadaic acid
Fig. 6. The role of Ca2+ in the timing
of the MAPK decrease. (A) A
representative recording from an egg
injected with MAPKAR and, once Ca
2+
oscillations had started, BAPTA (final
concentration of 2 mM) was added to
the drop containing the eggs in order
to terminate Ca2+ oscillations. The
response is typical of 33 eggs where
all eggs showed a change in MAPKAR
luminescence. (B) A representative
trace from a single egg injected with
WGA, as well as OGBD and MAPKAR
cRNA. The Ca2+ oscillations at
fertilization lasted longer than usual
and a similar change in MAPKAR
luminescence to the one shown was
seen in all 29 eggs. In A and B, sperm
were added to the dish before the start
of traces. (C,D) Eggs expressing
either MAPKAR or MAPKARD4
respectively were treated with 50 mM
roscovitine (added at the point
indicated by the arrow). Traces are
representative of three eggs for C and
12 eggs for D. The conditions for C
and D are as in Fig. 2.
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application, this implies that a kinase activity is still able to
phosphorylate ERK1 even when it is normally in the process of
being dephosphorylated. MEK is clearly the crucial kinase required
for restoring ERK1 activity as shown by experiments on
unfertilized eggs. As shown previously (Fig. 2), the addition of
the MEK inhibitor U0126 caused a relatively rapid change in
MAPKARD4 signal in unfertilized eggs. The subsequent addition
of okadaic acid did not affect the U0126-derived MAPKARD4
signal change, meaning that MAPK activity is not restored when
MEK is inactivated. Taken together, these data show MEK is still
active at the onset of ERK1 inactivation.
DISCUSSION
A decrease in MAPK activity is a common feature of egg
activation at fertilization in animals (Dupre´ et al., 2011;
Marangos et al., 2003, Dumollard et al., 2011). A reduction in
MAPK activity in mammalian eggs is essential for the
progression into interphase, marked by the formation of
pronuclei (Moos et al.,1995; Moos et al., 1996). Despite its
significance in completing egg activation, much less is known
about how the decrease in MAPK is controlled compared with
our knowledge about the decrease in MPF (CDK1–cyclin-B)
activity at fertilization (Ducibella and Fissore, 2008). Here, we
have used luciferase-based reporters to examine the specific
changes in Mos levels and MAPK activity in living eggs during
fertilization. To our knowledge, this is the first study in any
species to measure the dynamics of MAPK inactivation in
synchrony with Ca2+ oscillations in eggs at fertilization. In
addition, this is the first study to examine whether Mos
destruction occurs during activation at fertilization and to test
whether Mos plays a role in MAPK inactivation in mammalian
eggs.
The use of a split luciferase reporter of MAPK
A major problem in studying MAPK in mammalian eggs is the
limited material that is available to carry out precise biochemical
assays of activity. A FRET-based indicator for ERK activity has
been reported (Harvey et al., 2008). However, when we used this
in mouse eggs, we found that the small FRET change with this
reporter made it unsuitable for the long-term recordings that our
experiments require. In order to monitor the activation state of
ERK1, we used a split-luciferase chemiluminescent reporter
strategy based upon a click beetle luciferase. Our split-luciferase
reporter relies upon a conformational change associated with
dimerization of ERK1 or ERK2 that has been shown to occur in
response in double phosphorylation of ERK (Cobb and
Goldsmith, 2000). Using the split luciferase, we found a large
change in luminescence (,10-fold), which is characteristic of
split-luciferase reporters (Kim et al., 2007; Zhang et al., 2007).
The large change in luminescence we detect with our MAPK
probes appears to be linked to a phosphorylation-induced
conformational change and not dimerization as such. One of
our probes, MAPKARD4, uses an ERK1 sequence that is defective
in dimerization, and yet it still shows a 10-fold change in signal.
Because luciferase complementation effectively detects
molecular movement it appears that some conformation change
is occurring within our MAPK probes in response to
phosphorylation.
There are a number of probes that consist of a single molecule
with the N- and C-termini of luciferase at each end, and a pair of
nested proteins that bind to each other (Kim et al., 2007). In some
cases, interaction of the two internal components leads to an
increase in luciferase luminescence (Kim et al., 2007), whereas
with other reporters there is a luminescence decrease (Zhang et al.,
2007). Our MAPKAR reporter constructs, like endogenous ERK1/
2, are phosphorylated in unfertilized eggs, and after blocking MEK
with U0126 they are dephosphorylated, again like the endogenous
ERK1/2. At the same time, a marked increase in luminescence
is detected. Hence, the MAPKAR reporters show an inverse
relationship between phosphorylation (ERK interaction) and
luminescence (i.e. complementation of the N- and C-terminal
luciferase domains). Consequently, our probes cannot be
interpreted as directly monitoring ‘dimerization’ of ERK1
subunits given that one assumes this should involve subunits
coming together and lead to an increase in luminescence. The
importance of phosphorylation for the change in luminescence is
shown by the observation that a mutant MAPKAR, which lacks the
T202 and Y204 phosphorylation sites (Khokhlatchev et al., 1998),
did not show any change in luminescence with either U0126
application or at fertilization (Fig. 2; supplementary material Fig.
S2). These data show that ERK1 phosphorylation and activation
are reported effectively by our MAPKAR proteins.
Fig. 7. Effect of okadaic acid on eggs undergoing a decrease in MAPK activity. Conditions for fertilization were the same as Fig. 2, and eggs were
expressing MAPKARD4. (A) A representative trace from one of 11 eggs that was undergoing Ca
2+ oscillations and had started to show a change in MAPKARD4
luminescence. Okadaic acid (OA) 1 mM, was added at the arrow. Sperm were added to the dish at the point indicated by the lower arrow. (B) A
representative trace from one of 15 eggs expressing MAPKARD4 where 50 mM U0126 was added first exactly in the manner of Fig. 1C, except there was a later
addition of okadaic acid (1 mM) towards the end of the change in MAPKARD4 signal.
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We also found that the MAPKARD4 reporter showed a higher
basal luminescence level than the wild-type MAPKAR reporter.
This suggests that phosphorylation can still trigger a
conformation change between the two ERK1 protomers. We
can assume that there is likely to be a greater degree of
complementation between the split domains of luciferase with the
MAPKARD4 reporter. Notably, it has been previously shown that
the D4-ERK1 protein can be dephosphorylated at the same rate as
wild-type ERK1 (Lidke et al., 2010), so it is equally valid as a
reporter of ERK1 dephosphorylation for our studies of MAPK
inactivation. For our experiments, the MAPKARD4 protein was
valuable because the higher basal luminescence meant that it was
easier to determine the time at which the change in MAPK
activity occurred during egg activation at fertilization. As well as
the current use in mouse eggs, our MAPK probes might be
valuable for studies in other oocyte and eggs where MAPK
activity changes play a key role in maturation and activation after
fertilization (Dupre´ et al., 2011). In the sea urchin, biochemical
experiments have led to a disagreement about whether MAPK
activity is high or low in the unfertilized eggs, and to how it
changes in response to Ca2+ at fertilization (Philipova and
Whitaker, 1998; Carroll et al., 2000; Zhang et al., 2006). Live
imaging of eggs using our probes might help resolve such issues.
The timing of a late change in MAPK activity
In this study, we were able to monitor the dynamic changes
in ERK1 inactivation alongside Ca2+ oscillations, during
mammalian fertilization in single eggs. Ca2+oscillations served
as the activation stimulus and a temporal marker for the onset and
completion of egg activation events in mammals (Ducibella and
Fissore, 2008). Previous studies have shown that the onset of
MAPK inactivation occurs somewhere between second polar
body formation (,1 h after Ca2+ oscillations start) and the
formation of pronuclei, which occurs ,3 h later (Marangos et al.,
2003). Both MAPKAR and, particularly, MAPKARD4, reported
the initial MAPK decrease as being at ,2 h after Ca2+
oscillations commence. MAPK inactivation is known to be a
strict requirement for the pronuclei to form in mouse zygotes
(Moos et al., 1996), and our data are consistent with these
findings. A recent report measured the levels of phosphorylated
ERK1/2 in individual fertilizing mouse eggs using
immunostaining, and showed that the detectable decrease in
phosphorylation occurred after pronuclear formation (Soeda
et al., 2013). Thus a role of MAPK in pronuclear formation
was questioned. Our data suggests that a large fraction of the
MAPK decrease does indeed occur after pronuclear formation.
However, the onset of MAPK inactivation is apparent before
pronuclear formation, consistent with other reports measuring
MAPK activity in lysates (Marangos et al., 2003). Importantly,
our approach using MAPK indicators was able to bring a much
higher degree of time resolution and sensitivity compared to other
biochemical assays.
Despite an extended profile for the modification in MAPK
activity and its initiation during Ca2+ oscillations, the overall
MAPK change was only marginally affected by ongoing Ca2+
signals. Neither terminating nor extending the series of Ca2+
oscillations prevented the decrease in MAPK activity occurring.
This is consistent with a previous study that measured MAPK
using an in vitro kinase assay in mouse eggs injected with lectin
(Marangos et al., 2003). However, we did observe a small change
in the timing of the MAPK decrease by terminating Ca2+
oscillations early with BAPTA. This might be mediated by an
indirect effect upon MPF activity, because Ca2+ signals are
known to rapidly alter cyclin B levels (Madgwick and Jones,
2007). Our data do not support the idea that Ca2+ signals promote
MAPK activity (Hatch and Capco, 2001). We also found that
roscovitine-induced MPF activity decrease alone leads to a
decrease in MAPK activity (Phillips et al., 2002). Notably, we
found that the dynamics, with the distinct onset of MAPK
inactivation, induced by roscovitine was similar to that seen at
fertilization. Thus our data suggest that the MPF reduction
specifically triggers a sequence of events that initiates the onset of
MAPK inactivation.
The role of Mos in MAPK inactivation
Previous studies in Xenopus and mouse oocytes have shown that
Mos is the essential trigger for increased phosphorylation of both
MEK and ERK1/2. This leads to the increase in MAPK activity
during oocyte maturation (Verlhac et al., 1996; Dupre´ et al.,
2011). After fertilization, the MAPK pathway has decreased
activity, and the destruction of Mos has been implicated in
causing the reduced MAPK activity (Dupre´ et al., 2011). In
fertilizing ascidian oocytes the endogenous level of Mos has not
been measured, but the decline in Mos levels is evidently
necessary because any exogenous Mos expression prevents
fertilized oocytes from progressing to interphase, leading to
multiple rounds of polar body emission (Dumollard et al., 2011).
Mos–Cherry expression exerts these effects at very low
concentrations, which is consistent with studies in frog eggs,
where Mos has been measured at 3 nM (Ferrell, 1999). The
physiological levels of Mos in mouse eggs have not been reported
but it is likely to be relatively low because,1500 mouse eggs per
lane are required to detect Mos on western blots (Weber et al.,
1991). We investigated the destruction of Mos in fertilizing
mouse eggs using luciferase-tagged Mos, analogous to studies
that monitored cyclin B destruction at fertilization using GFP.
Based on our previous studies calibrating PLCf–luciferase signals
(Nomikos et al., 2011), we estimated that the Mos–luc expression
in our experiments was ,1–10 nM, which is well within
the physiological range. Despite this, we found no evidence
for increased destruction of Mos–luciferase at fertilization.
However, Mos–luc levels started to autonomously degrade in
unfertilized mouse eggs. These results are consistent with
previous studies showing that endogenous Mos protein declines
with time in unfertilized mouse eggs (Shoji et al., 2006; Suzuki
et al., 2010). Therefore, there is no indication that fertilization
causes increased Mos degradation. This refutes the idea that a
decline in Mos levels is responsible for MAPK inactivation in
mouse eggs.
In order to further investigate the role of Mos at fertilization,
we intentionally overexpressed Mos–luc at several orders of
magnitude greater concentrations than in the experiments
monitoring Mos–luc destruction. This Mos–luc overexpression
showed no effect in terms of pronuclear formation in mouse eggs,
as judged by the cessation of Ca2+ oscillations. In addition, we
measured MAPK activity, with MAPKAR, and simultaneously
overexpressed Mos–Cherry in fertilized mouse eggs. Given that
detecting a signal from a fluorescent protein, such as Cherry, in
cells requires concentrations of several hundred nanomolar
(Niswender et al., 1995), as with the Mos–luc, it appears that
we are expressing exogenous Mos protein orders of magnitude
above the endogenous levels in an egg. We again found that
overexpression of Mos–Cherry did not have any effect on MAPK
inactivation, which showed similar dynamics to that in normal
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fertilized mouse eggs. These data strongly suggest that Mos
degradation does not play a direct role in MAPK inactivation of
mouse eggs after fertilization. Interestingly, Mos expression can
block mitotic cell cycles in early ascidian embryos (Dumollard
et al., 2011), but Mos does not have such an effect in mouse
embryos (Kashima et al., 2007). Thus, there might be mechanistic
differences in the way that MAPK is regulated between
urochordate and mammalian zygotes.
MAPK inactivation is driven by a phosphatase activity
Mouse eggs can be induced to form pronuclei by treatment
with U0126, which inactivates MEK and leads to a decrease in
ERK1/2 activity (Phillips et al., 2002). Moreover, pronuclear
formation in mouse zygotes can be prevented by overexpression
of a constitutively active form of MEK. These data suggest a
model of egg activation in which there is a decrease in MEK and
then a decrease in ERK1 activity at fertilization. This scenario
presumes a decrease in upstream components, such as Mos, as
the primary cause of reduced MEK activity. Two separate lines
of evidence from the current study now suggest that the
anticipated upstream decline in MAPK pathway activity does
not apply to activation in mouse eggs. Firstly, as discussed
above, we did not detect evidence for any additional decrease in
Mos levels caused by fertilization. Secondly, we found that
okadaic acid fully reversed the marked MAPK decline after it
had been initiated at fertilization. Okadaic acid has previously
been shown to cause nuclear envelope breakdown and an
increase in MAPK activity when applied to pronuclear stage
mouse zygotes (Moos et al., 1995). However, this effect was
only reported for pronuclear stage zygotes treated with okadaic
acid for 4 h, so it was not possible to assess how rapidly and to
what extent MAPK activity was restored. Our data reveals that
okadaic acid induces rapid resumption of full MAPK activity,
and this suggests that Mos and MEK remain active in the egg
even at the end of the activation process. MEK activity might
prevail even in the face of a decline in Mos because a low
level of Mos appears to persist in activated eggs after pronuclear
formation (Weber et al., 1991), and this might still be
sufficient to maintain MEK activity. This activity retention is
feasible because MAPK cascades can display hysteresis, and
once activated by an upstream kinase, a very low level of
subsequent stimulation is sufficient to keep the pathway active
(Markevich et al., 2004).
Because the Mos–MEK pathway remains active, the simplest
explanation for MAPK inactivation in mouse zygotes is that an
increase in phosphatase activity drives down the MAPK activity
during fertilization. Previously, it has been shown that injecting
a constitutively active MEK blocks pronuclear formation in
fertilized mouse eggs (Moos et al., 1996). In this case, the
endogenous phosphatase activity might be insufficient to compete
against exogenous MEK. This putative phosphatase activity at
fertilization, which might overcome the endogenous MEK
activity, would need to be maintained for a prolonged period in
order to ensure no return of MAPK activity. The scenario we
propose is similar to mitosis, where there is a decrease in overall
phosphatase activity during entry into meiosis and then, with
progression towards interphase, there is a return to a prolonged
and higher level of phosphatase activity (Barr et al., 2011).
The identity of the phosphatase responsible for the decline in
MAPK activity remains to be elucidated, but could include
either PP2A or PP1 (Smith et al., 1998). Our proposed model
for the completion of activation of mouse zygotes is that a rise in
a phosphatase activity alone, which is independent of Mos,
drives a decrease in MAPK activity that leads to pronuclear
formation.
MATERIALS AND METHODS
Collection and handling of gametes
Mature mouse eggs were collected from super-ovulated MF1 female
mice as described previously (Saunders et al., 2002; Larman et al., 2004).
Procedures on mice were carried out under the regulations of a UK Home
Office Project Licence and were approved by a local Ethical Review
committee. The cumulus cells were dissociated from eggs by treatment
with hyaluronidase in M2 medium. Eggs were otherwise maintained at
37 C˚ in M2 and were microinjected using pressure applied to
micropipettes as described previously (Swann et al., 2009). For live
recordings from eggs, the zona pellucida of mouse eggs were removed by
brief treatment with acid Tyrodes solution, and the eggs were then
attached to a glass slide that formed the base of a heated chamber. The
chamber contained HKSOM medium with 100 mM luciferin (Larman
et al., 2004; Swann et al., 2009). For luminescence experiments, eggs
were equilibrated for ,1 h in medium containing luciferin before the
start of an experiment. Sperm were collected from the cauda epididymis
of F1 (C576CBA) males and capacitated in T6 medium for 2–3 h before
addition to eggs. To initiate fertilization, a small volume ,20 ml of
capacitated sperm was pipetted into the drop containing the eggs. All
chemicals were obtained from Sigma (Poole, Dorset UK) unless
otherwise stated.
Genetically encoded reporters
A bioluminescent reporter based upon interaction of the Renilla
luciferase N- and C-terminal domains that results from ERK2
dimerization has previously been characterized (Kaihara and Umezawa,
2008). However, Renilla luciferase uses coelenterazine as a substrate. We
used the click beetle luciferase to design and prepare a new ERK probe
because this enzyme uses the more stable luciferin as a substrate. The
click beetle luciferase emits green light and has been shown to be pH
insensitive over the range of pH 6–8 (Kim et al., 2007). To make a
luciferase reporter for human ERK1 phosphorylation and activity, two
tandem-connected ERK1 molecules were inserted between the N-
terminal (1–413) and C-terminal (395–543) regions of click beetle
luciferase (see Fig. 1). A 32-residue linker comprising 16 tandem
glycine-serine repeats (16GS) was inserted between the two ERK1
molecules that were amplified from a GFP–ERK1 template (http://www.
addgene.org/14747/). All PCR-amplified ERK1 constructs were first
inserted into the pCRH-Blunt II-TOPOH vector (Invitrogen) and then
subcloned into the pCR3 vector (Invitrogen). The denoted restriction sites
were used in construction of the ERK1 luciferase construct: BamHI–N-
Luc(1–413)-EcoRI–ERK1–EcoRI–16GS–ERK1–XhoI-C-Luc(395–543)–
XbaI. The construct is referred to as the MAPK activity reporter
(MAPKAR). A control ERK1–luciferase construct that is deficient in its
ability to dimerize was prepared using the dimerization-deficient mutant
ERK1D4(Pro193–Asp196) template which was amplified from the GFP–
ERK1-D4 plasmid kindly provided by Phillipe Lenormand (Lidke et al.,
2010). This is referred to as MAPKARD4. In addition, a luciferase
reporter containing the ERK1 double phosphorylation-site mutants
(T202A, Y204F) was generated with a Quick-Change Mutagenesis kit
(Stratagene) using the oligonucleotide primers 59-GGCTTCCTGGCG-
GAGTTTGTGGCTACGCG-39 and 59-CCCTCGCCGATGTACTGCA-
ACTGCGTGTA-39. This is referred to as MAPK-DM. Plasmids
encoding the mouse Mos (Verlhac et al., 2000) and ascidian Mos
(Dumollard et al., 2011) were kind gifts of Remi Dumollard. Mouse Mos
was amplified from pRN3-Mos, cloned into pCR3, and the click beetle
luciferase was then inserted in-frame at the Mos C-terminus. In order to
express the various expression constructs, we generated the
corresponding cRNAs for microinjection in mouse eggs. In vitro
synthesis of capped RNAs was performed using Nde1-linearized
plasmids with the T7 mScript2 Standard mRNA Production System
(Cambio) as per the manufacturer’s instructions, and these RNAs were
then polyadenylated as described previously (Swann et al., 2009). For
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antisense Mos–luc, the cRNA was made via the SP6 promoter using the
AmpliCap Message Maker kit (Epicentre).
Immunoblotting
To assess for the presence of endogenous and recombinant expression of
ERK1, mouse eggs were collected in SDS buffer, heated for 5 min at
100 C˚ and proteins were separated by SDS-PAGE (Nomikos et al., 2011).
Immunoblotting was then performed as described previously (Verlhac
et al., 1996). Following transfer onto polyvinylidene difluoride membrane
(Immobilon-P; Millipore) using a semi-dry transfer system (Trans-Blot
SD; Bio-Rad) in buffer (48 mM Tris-HCl, 39 mM glycine, 0.0375% SDS)
at 22 V for 4 h and blocking overnight in 5% skimmed (low-fat) milk in
TBS (10 mM Tris-HCl, pH 7.5, 140 mM NaCl) containing 0.1% Tween-
20 (TBS/Tween), the membrane was incubated for 1 h with the appropriate
primary antibody. ERK1 was detected using monoclonal antibody against
diphosphorylated ERK1/2 (1:1000, M9692 Sigma) and ERK1 (1:500,
G-8; sc-271269, Santa Cruz Biotechnology) antibodies. Detection of
horseradish-peroxidase-coupled secondary antibody was achieved using
enhanced chemiluminescence detection (ECL, Amersham Biosciences).
All experiments were repeated at least three times.
Luminescence and fluorescence measurement
In our experiments, the luminescence of eggs depicts the emission
from the recombinant luciferase-tagged proteins expressed from the
cRNAs that we injected. Eggs were incubated in M2 medium for 2–3 h to
allow expression of the luciferase-based constructs before starting an
experiment. The fluorescence recording is to detect the Ca2+-sensitive
dye Oregon Green BAPTA dextran (OGBD) (Invitrogen, UK). This
consisted of a stock of concentration of 1 mM in KCl/Hepes buffer that
was then diluted 1:1 with cRNA for a particular luciferase construct. The
luminescence and fluorescence measurements were recorded from eggs
using one of two intensified charge-coupled device (ICCD) photon-
counting imaging systems (Photek Ltd, St Leonards on Sea, UK) that
switch between recording modes and have been described previously
(Campbell and Swann, 2006; Swann et al., 2009). Mos–Cherry
fluorescence from eggs was measured using a 550-nm excitation and a
590-nm long-pass emission filter with a 565-nm dichroic mirror, at the
start of the experiment. Then, during the rest of the experiment, a 490-nm
and 520-nm filter block was used to measure OGBD fluorescence and
luciferase luminescence (Campbell and Swann, 2006). Unless otherwise
stated, the luminescence traces were filtered using a running average of
5 min. The fluorescence traces are all in arbitrary units because we only
recorded the occurrence of Ca2+ oscillations and not their absolute
magnitude. For in vitro fertilization experiments, data were only analyzed
for eggs where the Ca2+ oscillations could be recorded from start to finish
without a major deviation of the baseline, which otherwise occurred
occasionally in eggs that moved during recording. Data was collected and
analyzed using the Photek camera software and SigmaPlot. Further
details of the imaging system and methodology has been given previously
(Campbell and Swann, 2006; Swann et al., 2009). These experiments
were carried out over the course of 2 years and we noted that there was
some variation in the timing of Ca2+ oscillations seen in control
fertilizations, and so key experiments compared interventions with
groups of eggs studied within the same month as control eggs.
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